Children’s nonprofit Magic Foundation just held its 28th Annual Convention, an educational experience providing a glimmer of hope to children impacted by endocrine disorder and their families. Speakers at the three-day conference covered topics including physical health, mental health, insurance, genetics, education issues and more.
Complementing the educational sessions, an exhibit hall featuring a variety of science-themed activities gave families the opportunity to learn about potential treatments and medications in a lighthearted way. Perfectly aligning with this theme, pharmaceutical company Ascendis partnered with Visual Communications to transform its booth space into a fully branded liquid nitrogen ice cream station.
After choosing between four decadent flavors, our ice cream pros combined ingredients with a dash of liquid nitrogen, prompting a cool fog to billow from the mixture. Children and their families were mesmerized by the mystical dessert whipped up right before their eyes. Not only was the result fresher than traditional ice cream, but the flash-freeze technique also gave it a creamier texture and richer taste.
As families enjoyed their ice cream, Ascendis reps were available to help answer any questions regarding how its medications can help make a positive difference in their children’s lives.
After getting their sugar fix, families flocked to the pharmaceutical company’s custom photo booth station. Featuring a giant version of the classic photo strip, this unique photo booth gave children the chance to be silly and make big memories.
The MAGIC Foundation is a charitable non-profit organization created to provide support services for the families of children afflicted with a wide variety of chronic and/or critical disorders, syndromes and diseases that affect a child’s growth. The MAGIC Foundation’s mission is to reduce the emotional and physical trauma caused by growth disorders, resulting in healthier, happier children and consequently, adults.
Visual supports clients of all sizes and industries around the globe. Visual devises, designs, engineers, builds, manages and executes anything it’s clients imagine. A principal is directly involved in every project, bringing vast experience to the table and facilitating projects’ forward motion.
Ascendis Pharma AS (Ascendis Pharma) is a biopharmaceutical company that focuses on developing drugs for endocrinology and oncology indications. It is investigating TransCon hGH, a long-acting human growth hormone prodrug targeting GHD (growth hormone deficiency); TransCon PTH drug to treat hypoparathyroidism by restoring physiologic levels of PTH (parathyroid hormone); and TransCon CNP, a CNP (C-type natriuretic peptide) drug against achondroplasia (ACH).
SKYTROFA is a prescription medication for the replacement of growth hormone in children 1 year old or older who weigh at least 26 pounds (11.5 kilograms) with growth hormone deficiency (GHD).
